德利克斯任命戴维·吉尔为非执行董事. Telix appoints David Gill as Non-Executive Director.

德力克斯制药公司任命戴维·吉尔为非执行董事, Telix Pharmaceuticals has appointed David Gill as a Non-Executive Director, effective immediately. 吉尔在生命科学领域和战略金融方面拥有丰富的经验. Gill brings extensive experience in the life sciences sector and strategic finance. 公司表示,此次任命支持其持续增长和战略发展. The company stated this appointment supports its continued growth and strategic development.